If you have achieved your weight loss goal entirely, the conversation shifts from dose escalation to dose maintenance, which is a different discussion that involves your provider and depends on individual factors like metabolic rate, dietary habits, and whether the weight remains stable at a reduced dose
In accordance with the guidelines outlined in the National Medical Products Administration (NMPA) Technical Guideline for Bioequivalence Studies of Generic Chemical Drugs with Pharmacokinetic Parameters as the Endpoints, and considering the characteristics of the drug used in this study, the overall design was a single-center, open-label, randomized, two-formulation, two-period, two-way crossover, fasting pharmacokinetic study
Food and Drug Administration expands the drugs potential uses, Harris cautions the medications arent a one-size-fits-all solution and should be paired with medical supervision and lifestyle changes
In that trial, GLP-1 therapy plus exercise also produced larger reductions in abdominal fat and systematic inflammation than GLP-1 therapy alone [163]